Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations - GISSI-Prevenzione mortality risk chart

被引:114
作者
Marchioli, R [1 ]
Avanzini, F [1 ]
Barzi, F [1 ]
Chieffo, C [1 ]
Di Castelnuovo, A [1 ]
Franzosi, MG [1 ]
Geraci, E [1 ]
Maggioni, AP [1 ]
Marfisi, RM [1 ]
Mininni, N [1 ]
Nicolosi, GL [1 ]
Santini, M [1 ]
Schweiger, C [1 ]
Tavazzi, L [1 ]
Tognoni, G [1 ]
Valagussa, F [1 ]
机构
[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, GISSI, Prevenz Secretariat, I-66030 Santa Maria Imbaro, Italy
关键词
myocardial infarction; prevention; prediction; risk factors; congestive heart failure; arrhythmias; residual; ischaemia;
D O I
10.1053/euhj.2000.2544
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To present and discuss a comprehensive and ready to use prediction model of risk of death after myocardial infarction based on the very recently concluded follow-up of the large GISSI-Prevenzione cohort and on the integrated evaluation of different categories of risk factors: those that are non-modifiable. and those related to lifestyles, co-morbidity, background. and other conventional clinical complications produced by the index myocardial infarction. Methods The 11 324 men and women recruited in the study within 3 months from their index myocardial infarction have been followed-up to 4 years. The following risk factors have been used in a Cox proportional hazards model: non-modifiable risk factors: age and sex, complications after myocardial infarction: indicators of left ventricular dysfunction (signs or symptoms of acute left ventricular failure during hospitalization. ejection fraction, NYHA class and extent or ventricular asynergy at echocardiography), indicators of electrical instability (number of premature ventricular beats per hour, sustained or repetitive arrhythmias during 24-h Holler monitoring), indicators of residual ischaemia (spontaneous angina pectoris after myocardial infarction, Canadian Angina Classification class, and exercise testing results); cardiovascular risk factors: smoking habits, history of diabetes mellitus and arterial hypertension, systolic and diastolic blood pressure. blood total and HDL cholesterol, triglycerides, fibrinogen, leukocytes count, intermittent claudication. and heart rate. Multiple regression modelling was assessed by receiver operating characteristic (ROC) analysis. Generalizability of the models was assessed through cross validation and bootstrapping techniques. Population and Results During the 4 years of follow-up, a total of 1071 patients died. Age and left ventricular dysfunction were the most relevant predictors of death. Because of pharmacological treatments, total blood cholesterol, triglycerides, and blood pressure values were not significantly associated with prognosis. Sex-specific prediction equations were formulated to predict risk of death according to age, simple indicators of left ventricular dysfunction., electrical instability, and residual ischaemia along with the following cardiovascular risk factors: smoking habits, history of diabetes mellitus and arterial hypertension, blood HDL cholesterol, fibrinogen, leukocyte count, intermittent claudication, and heart rate. The predictive models produced on the basis of information available in the routine conditions of clinical care after myocardial infarction provide ready to use and highly discriminant criteria to guide secondary prevention strategies. Conclusions and Implications Besides documenting what should be the preferred and practicable focus of clinical attention for today's patients, the experience of GISSI-Prevenzione suggests that periodically and prospectively collected databases on 'naturalistic' cohorts could be an important option for updating and verifying the impact of guidelines, which should incorporate the different components of the complex profile of cardiovascular risk. The GISSI Prevenzione risk function is a simple tool to predict risk of death and to improve clinical management of subjects with recent myocardial infarction. The use of predictive risk algorithms can favour the shift from medical logic, based on the treatment of single risk factors, to one (C) 2001 The European Society of Cardiology.
引用
收藏
页码:2085 / 2103
页数:19
相关论文
共 66 条
  • [1] [Anonymous], 1989, SAS STAT US GUID VER
  • [2] [Anonymous], HEART S2
  • [3] Early and pre-discharge aspirin administration among patients with acute myocardial infarction: Current clinical practice and trends in the United States
    Becker, RC
    Burns, M
    Gore, JM
    Lambrew, C
    French, W
    Rogers, WJ
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2000, 9 (03) : 207 - 215
  • [4] Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) : 1360 - 1369
  • [5] ON THE USE OF A LOGISTIC RISK SCORE IN PREDICTING RISK OF CORONARY HEART-DISEASE
    CHAMBLESS, LE
    DOBSON, AJ
    PATTERSON, CC
    RAINES, B
    [J]. STATISTICS IN MEDICINE, 1990, 9 (04) : 385 - 396
  • [6] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT
    COLLINS, R
    PETO, R
    MACMAHON, S
    HEBERT, P
    FIEBACH, NH
    EBERLEIN, KA
    GODWIN, J
    QIZILBASH, N
    TAYLOR, JO
    HENNEKENS, CH
    [J]. LANCET, 1990, 335 (8693) : 827 - 838
  • [7] COLLINS R, 1992, TXB HYPERTENSION, P1156
  • [8] COX DR, 1972, J R STAT SOC B, V34, P187
  • [9] Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies
    Danesh, J
    Collins, R
    Appleby, P
    Peto, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1477 - 1482
  • [10] THE PREDICTIVE VALUE OF ADMISSION HEART-RATE ON MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    DISEGNI, E
    GOLDBOURT, U
    REICHERREISS, H
    KAPLINSKY, E
    ZION, M
    BOYKO, V
    BEHAR, S
    NEUFELD, HN
    AGMON, J
    ABINADER, E
    FRIEDMAN, Y
    HAMMERMAN, H
    KAULI, N
    KISHON, Y
    MANDELZWEIG, L
    PALANT, A
    PELLED, B
    RABINOWITZ, B
    REISIN, L
    RISS, E
    ROSENFELD, T
    SCHLESINGER, Z
    SCLAROVSKY, S
    ZAHAVI, I
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (10) : 1197 - 1205